• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅骨朗格汉斯细胞组织细胞增生症 23 例

Langerhans cell histiocytosis of the skull in 23 children.

机构信息

Department of Neurosurgery, Shanghai Children's Hospital, Shanghai Jiao Tong University, Luding Rd. 355, Shanghai, People's Republic of China.

出版信息

Eur J Med Res. 2024 Feb 17;29(1):136. doi: 10.1186/s40001-024-01727-5.

DOI:10.1186/s40001-024-01727-5
PMID:38368348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10874530/
Abstract

OBJECTIVE

To explore the clinical features, diagnosis, treatment and prognosis of Langerhans cell histiocytosis (LCH) of the skull in children.

METHODS

This study retrospectively summarized the clinical manifestations, treatment methods and follow-up status of children with skull LCH who were admitted to the Department of Neurosurgery of Shanghai Children's Hospital from January 2014 to June 2021.

RESULTS

A total of 23 patients confirmed by histology as LCH received hospitalization treatment, including 14 males and 9 females, aged (5.76 ± 3.86) years old. The clinical manifestations were mostly incidentally discovered head masses that gradually enlarged (19 cases, 82.61%). Only 2 cases are affected by multiple systems, while the rest are affected by single systems. 9 patients were involved in multiple skull lesions, and 14 patients had local skull lesions. All patients underwent surgical intervention, with 17 patients undergoing total resection and 6 patients undergoing biopsy. 21 patients received chemotherapy after surgery. The median follow-up was 2.46 years (range 0.33-6.83 years). 21 patients had their symptoms and signs under control or even resolved, and 2 patients experienced recurrence during follow-up. The overall control rate reached 91.30%.

CONCLUSION

Personalized treatment plans according to different clinical types. Regular outpatient follow-up is crucial to monitor disease recurrence and late effects.

摘要

目的

探讨儿童颅骨朗格汉斯细胞组织细胞增生症(LCH)的临床特征、诊断、治疗及预后。

方法

本研究回顾性总结了 2014 年 1 月至 2021 年 6 月期间上海儿童医学中心神经外科收治的 23 例经组织学证实为 LCH 的颅骨 LCH 患儿的临床表现、治疗方法和随访情况。

结果

共 23 例患者经组织学确诊为 LCH,均接受住院治疗,其中男 14 例,女 9 例,年龄(5.76±3.86)岁。临床表现多为逐渐增大的偶然发现的头部肿块(19 例,82.61%)。仅 2 例为多系统受累,其余均为单系统受累。9 例患者有多个颅骨病变,14 例患者有局部颅骨病变。所有患者均接受手术干预,17 例患者行全切术,6 例患者行活检术。术后 21 例行化疗。中位随访时间为 2.46 年(范围 0.33-6.83 年)。21 例患者症状和体征得到控制甚至缓解,2 例患者在随访中复发。总体控制率达 91.30%。

结论

根据不同的临床类型制定个体化的治疗方案。定期门诊随访对于监测疾病复发和晚期效应至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6938/10874530/96b0b24d6df6/40001_2024_1727_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6938/10874530/3558fba43ffc/40001_2024_1727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6938/10874530/96b0b24d6df6/40001_2024_1727_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6938/10874530/3558fba43ffc/40001_2024_1727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6938/10874530/96b0b24d6df6/40001_2024_1727_Fig2_HTML.jpg

相似文献

1
Langerhans cell histiocytosis of the skull in 23 children.颅骨朗格汉斯细胞组织细胞增生症 23 例
Eur J Med Res. 2024 Feb 17;29(1):136. doi: 10.1186/s40001-024-01727-5.
2
Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.颅骨朗格汉斯细胞组织细胞增多症:18例回顾性研究
Ann Palliat Med. 2017 Apr;6(2):159-164. doi: 10.21037/apm.2016.11.04. Epub 2016 Nov 28.
3
Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.颞骨朗格汉斯细胞组织细胞增多症:单中心29例病例回顾
Laryngoscope. 2016 Aug;126(8):1899-904. doi: 10.1002/lary.25773. Epub 2015 Nov 4.
4
Primary head and neck Langerhans cell histiocytosis in children.儿童原发性头颈部朗格汉斯细胞组织细胞增多症
Otolaryngol Head Neck Surg. 2006 Aug;135(2):312-7. doi: 10.1016/j.otohns.2006.03.019.
5
[Clinical analysis of Langerhans cell histiocytosis originating in the base of nasal skull].[起源于颅底的朗格汉斯细胞组织细胞增多症的临床分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Sep;33(9):883-886. doi: 10.13201/j.issn.1001-1781.2019.09.020.
6
Sonographic diagnosis and monitoring of localized langerhans cell histiocytosis of the skull.颅骨局限性朗格汉斯细胞组织细胞增多症的超声诊断与监测
J Clin Ultrasound. 2013 Mar-Apr;41(3):134-9. doi: 10.1002/jcu.21988. Epub 2012 Sep 18.
7
Langerhans' cell histiocytosis of the head and neck in children.儿童头颈部朗格汉斯细胞组织细胞增多症
Ann Otol Rhinol Laryngol. 1995 Mar;104(3):173-80. doi: 10.1177/000348949510400301.
8
Clinical features and treatment outcomes of Langerhans cell histiocytosis of the spine.脊柱朗格汉斯细胞组织细胞增生症的临床特征和治疗结果。
Spine J. 2018 Oct;18(10):1755-1762. doi: 10.1016/j.spinee.2018.02.025. Epub 2018 Mar 2.
9
Langerhans' cell histiocytosis: paediatric head and neck study.朗格汉斯细胞组织细胞增多症:儿科头颈研究
J Otolaryngol. 1999 Oct;28(5):266-72.
10
Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.朗格汉斯细胞组织细胞增多症单系统受累患儿的预后:中国上海某单中心的回顾性研究
Pediatr Hematol Oncol. 2018 Oct-Nov;35(7-8):385-392. doi: 10.1080/08880018.2018.1545814. Epub 2019 Jan 29.

本文引用的文献

1
Incidental finding of Langerhans cell histiocytosis of temporoparietal bone - A case report.颞顶骨朗格汉斯细胞组织细胞增多症的偶然发现——一例报告
Int J Surg Case Rep. 2021 Aug;85:106179. doi: 10.1016/j.ijscr.2021.106179. Epub 2021 Jul 7.
2
Langerhans cell histiocytosis: Version 2021.朗格汉斯细胞组织细胞增生症:2021 年版。
Hematol Oncol. 2021 Jun;39 Suppl 1(Suppl 1):15-23. doi: 10.1002/hon.2857.
3
Unusual sites of bone involvement in Langerhans cell histiocytosis: a systematic review of the literature.朗格汉斯细胞组织细胞增生症中骨骼受累的不常见部位:文献系统回顾。
Orphanet J Rare Dis. 2021 Jan 2;16(1):1. doi: 10.1186/s13023-020-01625-z.
4
Childhood Langerhans cell histiocytosis: a disease with many faces.儿童朗格汉斯细胞组织细胞增生症:一种具有多种表现的疾病。
World J Pediatr. 2019 Dec;15(6):536-545. doi: 10.1007/s12519-019-00304-9. Epub 2019 Aug 28.
5
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.实时基因组分析有助于明确组织细胞增多症的早期激酶结构域 BRAF 改变,从而改善治疗结局。
JCI Insight. 2017 Feb 9;2(3):e89473. doi: 10.1172/jci.insight.89473.
6
Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.颅骨朗格汉斯细胞组织细胞增多症:18例回顾性研究
Ann Palliat Med. 2017 Apr;6(2):159-164. doi: 10.21037/apm.2016.11.04. Epub 2016 Nov 28.
7
Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.朗格汉斯细胞组织细胞增多症发病机制的见解:靶向治疗的发展
Immunotargets Ther. 2016 Oct 12;5:81-91. doi: 10.2147/ITT.S91058. eCollection 2016.
8
Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.由阿糖胞苷、长春新碱和泼尼松龙组成的强化延长治疗可改善多系统朗格汉斯细胞组织细胞增多症患者的预后:日本朗格汉斯细胞组织细胞增多症研究组-02方案研究结果
Int J Hematol. 2016 Jul;104(1):99-109. doi: 10.1007/s12185-016-1993-3. Epub 2016 Apr 4.
9
Solitary Langerhans cell histiocytosis of the occipital condyle: a case report and review of the literature.枕髁孤立性朗格汉斯细胞组织细胞增多症:一例报告并文献复习
Childs Nerv Syst. 2016 Feb;32(2):399-404. doi: 10.1007/s00381-015-2850-z. Epub 2015 Aug 26.
10
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.克拉屈滨与阿糖胞苷治疗难治性多系统朗格汉斯细胞组织细胞增多症:一项国际2期研究的结果
Blood. 2015 Sep 17;126(12):1415-23. doi: 10.1182/blood-2015-03-635151. Epub 2015 Jul 20.